FDA Clears Rune Labs’ Parkinson’s Monitoring System to Collect Patient Data Via Apple Watch
Rune Labs' software ecosystem for Parkinson's disease has been cleared by the FDA to collect patient symptom data via an Apple Watch.
Rune Labs' software ecosystem for Parkinson's disease has been cleared by the FDA to collect patient symptom data via an Apple Watch.
Saranas, which is focused on improving patient outcomes through detection and monitoring of internal bleeding, received the patent from the U.S. Department of Commerce’s United States Patent and Trademark Office.
Vital signs monitors frequently top the U.S. FDA’s recall list, due to their ability to cause patient harm. In fact, the FDA database includes many reports of non-invasive blood pressure failures, incorrect oxygen values, electrocardiogram (ECG) signal errors, and more. This compounds the importance of ensuring patient monitoring systems are accurate and safe to use.
Rune Labs' software ecosystem for Parkinson's disease has been cleared by the FDA to collect patient symptom data via an Apple Watch.